137 related articles for article (PubMed ID: 37008718)
41. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
[TBL] [Abstract][Full Text] [Related]
42. A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study.
Dumortier J; Duvoux C; Dubel L; Bazin F; Houssel-Debry P
Ann Transplant; 2019 Aug; 24():506-516. PubMed ID: 31451681
[TBL] [Abstract][Full Text] [Related]
43. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
[TBL] [Abstract][Full Text] [Related]
44. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.
Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R
S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689
[TBL] [Abstract][Full Text] [Related]
45. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
46. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients.
Griffin SP; Nelson JE
Prog Transplant; 2016 Dec; 26(4):314-321. PubMed ID: 27628498
[TBL] [Abstract][Full Text] [Related]
47. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
48. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.
Varghese J; Reddy MS; Venugopal K; Perumalla R; Narasimhan G; Arikichenin O; Shanmugam V; Shanmugam N; Srinivasan V; Jayanthi V; Rela M
Indian J Gastroenterol; 2014 May; 33(3):219-25. PubMed ID: 24740447
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
[TBL] [Abstract][Full Text] [Related]
50. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
Langone A; Steinberg SM; Gedaly R; Chan LK; Shah T; Sethi KD; Nigro V; Morgan JC;
Clin Transplant; 2015 Sep; 29(9):796-805. PubMed ID: 26113208
[TBL] [Abstract][Full Text] [Related]
51. Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study.
Upjohn E; Bhore R; Taylor RS
Dermatol Surg; 2012 Sep; 38(9):1448-55. PubMed ID: 22587392
[TBL] [Abstract][Full Text] [Related]
52. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
Prasad GV; Nash MM; Keough-Ryan T; Shapiro RJ
J Nephrol; 2010; 23(3):274-81. PubMed ID: 20383867
[TBL] [Abstract][Full Text] [Related]
53. Muscle mass, muscle strength and mortality in kidney transplant recipients: results of the TransplantLines Biobank and Cohort Study.
van Vliet IMY; Post A; Kremer D; Boslooper-Meulenbelt K; van der Veen Y; de Jong MFC; Pol RA; ; Jager-Wittenaar H; Navis GJ; Bakker SJL
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2932-2943. PubMed ID: 36891995
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
Lichvar A; Tremblay S; Naik D; Lipscomb J; King E; Vinks AA; Christians U; Alloway RR
Pharmacotherapy; 2019 May; 39(5):564-575. PubMed ID: 30892704
[TBL] [Abstract][Full Text] [Related]
55. Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes.
González-Vílchez F; Crespo-Leiro MG; Delgado-Jiménez J; Pérez-Villa F; Segovia-Cubero J; Díaz-Molina B; Mirabet-Pérez S; Arizón Del Prado JM; Blasco-Peiró T; Martínez-Sellés M; Almenar-Bonet L; Garrido-Bravo I; Rábago G; Vázquez de Prada JA
Rev Esp Cardiol (Engl Ed); 2022 Feb; 75(2):129-140. PubMed ID: 33744197
[TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
[TBL] [Abstract][Full Text] [Related]
57. Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients.
Hind T; Lui S; Moon E; Broad K; Lang S; Schreiber RA; Armstrong K; Blydt-Hansen TD
Pediatr Transplant; 2021 Jun; 25(4):e14005. PubMed ID: 33769652
[TBL] [Abstract][Full Text] [Related]
58. An Integrated Clinical and Genetic Prediction Model for Tacrolimus Levels in Pediatric Solid Organ Transplant Recipients.
Min S; Papaz T; Lambert AN; Allen U; Birk P; Blydt-Hansen T; Foster BJ; Grasemann H; Hamiwka L; Litalien C; Ng V; Berka N; Campbell P; Daniel C; Saw CL; Tinckam K; Urschel S; Van Driest SL; Parekh R; Mital S
Transplantation; 2022 Mar; 106(3):597-606. PubMed ID: 33755393
[TBL] [Abstract][Full Text] [Related]
59. Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
Ritter A; Badir S; Mansour M; Segal Z; Ad-El D; Bachar G; Shpitzer T; Popovtzer A; Mizrachi A
Head Neck; 2021 Mar; 43(3):884-894. PubMed ID: 33247523
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
Jonker EFF; Uijlings MAC; Visser LG; Soonawala D
Vaccine; 2019 May; 37(23):3133-3139. PubMed ID: 31029516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
